[go: up one dir, main page]

DE60011062D1 - Verfahren zur herstellung von selbstvernetzten hyaluronsäuren und deren derivaten mittels superkritischer anti-lösungsmittel - Google Patents

Verfahren zur herstellung von selbstvernetzten hyaluronsäuren und deren derivaten mittels superkritischer anti-lösungsmittel

Info

Publication number
DE60011062D1
DE60011062D1 DE60011062T DE60011062T DE60011062D1 DE 60011062 D1 DE60011062 D1 DE 60011062D1 DE 60011062 T DE60011062 T DE 60011062T DE 60011062 T DE60011062 T DE 60011062T DE 60011062 D1 DE60011062 D1 DE 60011062D1
Authority
DE
Germany
Prior art keywords
derivatives
solvents
self
production
cross
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60011062T
Other languages
English (en)
Inventor
Paolo Pallado
Marco Baggio
Carbonare Maurizio Dalle
Lanfranco Callegaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia Farmaceutici SpA
Original Assignee
Fidia Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici SpA filed Critical Fidia Farmaceutici SpA
Application granted granted Critical
Publication of DE60011062D1 publication Critical patent/DE60011062D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/54Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
DE60011062T 1999-04-08 2000-03-30 Verfahren zur herstellung von selbstvernetzten hyaluronsäuren und deren derivaten mittels superkritischer anti-lösungsmittel Expired - Lifetime DE60011062D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999PD000070A IT1306643B1 (it) 1999-04-08 1999-04-08 Processo per la preparazione dei composti autoreticolati dell'acidoialuronico e dei suoi derivati ottenibili mediante la tecnica
PCT/EP2000/002814 WO2000061640A1 (en) 1999-04-08 2000-03-30 Process for the preparation of autocrosslinked compounds of hyaluronic acid and the derivatives thereof by the supercritical antisolvent technique

Publications (1)

Publication Number Publication Date
DE60011062D1 true DE60011062D1 (de) 2004-07-01

Family

ID=11392546

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60011062T Expired - Lifetime DE60011062D1 (de) 1999-04-08 2000-03-30 Verfahren zur herstellung von selbstvernetzten hyaluronsäuren und deren derivaten mittels superkritischer anti-lösungsmittel

Country Status (9)

Country Link
US (1) US6552184B1 (de)
EP (1) EP1165619B1 (de)
JP (1) JP2002542316A (de)
AT (1) ATE267843T1 (de)
AU (1) AU769657B2 (de)
CA (1) CA2369275C (de)
DE (1) DE60011062D1 (de)
IT (1) IT1306643B1 (de)
WO (1) WO2000061640A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2295005T3 (es) 1999-01-13 2008-04-16 Alchemia Oncology Pty Limited Uso de hialuronano para la preparacion de un medicamento para la mejora de la eficacia de farmacos citotoxicos.
AUPQ879500A0 (en) * 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
US9066919B2 (en) * 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
WO2003018062A1 (en) * 2001-08-27 2003-03-06 Meditech Research Limited Improved therapeutic protocols
US8937052B2 (en) 2005-07-27 2015-01-20 Alchemia Oncology Pty Limited Therapeutic protocols using hyaluronan
EA013877B1 (ru) 2005-09-07 2010-08-30 Алкемиа Онколоджи Пти Лимитед Терапевтические композиции, содержащие гиалуроновую кислоту и терапевтические антитела, а также способы лечения
EP1942117A1 (de) * 2006-12-29 2008-07-09 Sigea S.R.L. Derivate aus Carboxypolysacchariden
EP2209814B1 (de) * 2007-11-13 2017-01-25 Bio-Technology General (Israel) Ltd. Verfahren zur sterilisation durch filtration in verdünnter lösung für viskoelastische biopolymere
WO2020016820A1 (en) 2018-07-18 2020-01-23 Bio-Technology General (Israel) Ltd. Process of, and arrangement for, sterile filtering a non-newtonian liquid and formulation of a liquid obtainable thereby

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
EP0817620B1 (de) 1995-03-28 2002-01-30 Fidia Advanced Biopolymers, S.R.L. Nanosphären mit einem biokompatiblen polysaccharid
WO1997031691A1 (en) * 1996-03-01 1997-09-04 The University Of Kansas Methods and apparatus for particle precipitation and coating using near-critical and supercritical antisolvents
US5833891A (en) * 1996-10-09 1998-11-10 The University Of Kansas Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
IT1287698B1 (it) * 1996-08-29 1998-08-18 Fidia Advanced Biopolymers Srl Fili da sutura essenzialmente costituiti da derivati esterei dello acido ialuronico

Also Published As

Publication number Publication date
US6552184B1 (en) 2003-04-22
IT1306643B1 (it) 2001-10-02
AU4745900A (en) 2000-11-14
ATE267843T1 (de) 2004-06-15
CA2369275A1 (en) 2000-10-19
AU769657B2 (en) 2004-01-29
EP1165619A1 (de) 2002-01-02
WO2000061640A1 (en) 2000-10-19
ITPD990070A1 (it) 2000-10-08
CA2369275C (en) 2009-02-03
EP1165619B1 (de) 2004-05-26
JP2002542316A (ja) 2002-12-10

Similar Documents

Publication Publication Date Title
DE60316291D1 (de) Esterderivate von hyaluronsäure zur herstellung von hydrogelmaterialien durch photohärtung
BR9707223A (pt) Produtos de colágeno e derivados de colágeno isentos de prìon e implantes para múltiplas aplicações biomédicas ; métodos de obtenção dos mesmos
DK0822839T3 (da) Kunstig hud indeholdende som bærer bioforenelige materialer baseret på hyaluronsyrederivater
NL300168I1 (nl) Tweewaardige metaalzouten van 2-N,N-di (carboxymethyl)amino-3-cyaan-4-carboxymethyl-5-thiofeencarbonzuur, werkwijze voor de bereiding ervan en deze b evattende farmaceutische preparaten.
CN102470190B (zh) 适用于治疗骨关节炎、韧带损伤和关节失调的生物材料
ATE271886T1 (de) Hyaluronsäure enthaltende zusammensetzungen zur abgabe osteogener proteine
DK1235536T3 (da) Medicinsk anordning, der omfatter en syntetisk overflade med nukleinsyre til in vivoinduktion af en endothelisering af anordningen
BRPI0414455A (pt) métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins
DE69827651D1 (de) Verwendung von tempol zur behandlung von essentiellem hochdruck
ATE153696T1 (de) Verfahren und desoxyribonukleinsäure zur herstellung von gewebefaktor-protein
IT1306644B1 (it) Strutture tridimensionali comprendenti derivati dell'acido ialuronicoottenibili mediante la tecnica antisolvente supercritico.
CN107115561B (zh) 一种3d打印支架材料及其制备方法和应用
AR050010A1 (es) Acido hialuronico reticulado soluble en agua, su procedimiento de preparacion, implanto que contiene dicho acido hialuronico reticulado, y su utilizacion
DE60011062D1 (de) Verfahren zur herstellung von selbstvernetzten hyaluronsäuren und deren derivaten mittels superkritischer anti-lösungsmittel
KR20150128481A (ko) 세포외기질 및 온도감응성 고분자를 포함하는 생체 피부용 조성물
DE69133338D1 (de) Bmp-5-derivate
EP2480239A1 (de) Zusammensetzung mit einer hämatischen komponente und ihre verwendung zur behandlung degenerativer gelenkerkrankungen
ATE172117T1 (de) Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten
DE69024053D1 (de) Behandlung zur ermässigung von ödem und muskelschäden.
Correia et al. Development and in vitro assessment of injectable, adhesive, and self-healing chitosan-based hydrogels for treatment of spinal cord injury
KR102048914B1 (ko) 콘드로이틴설페이트가 함유된 젤란검 하이드로겔 조성물
KR20150131864A (ko) 어류의 정액 또는 정소로부터 분리된 디엔에이 단편 혼합물을 함유하는 회전근개 파열의 예방 또는 치료용 약학 조성물
US20020001623A1 (en) Organism-compatible materials with combined extra-cellular matrices, extracellular-matrix preparations, and production methods
ATE228843T1 (de) Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit
DE69227042D1 (de) Verfahren und zusammensetzungen zur verminderung von blutverlust

Legal Events

Date Code Title Description
8332 No legal effect for de